KalVista Pharmaceuticals, Inc. (KALV)

CIK 1348911 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for KalVista Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001214659-26-010418
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000933
Aug 14, 2026SCHEDULE 13G/A0001104659-26-096807
Aug 11, 2026SCHEDULE 13G0001104659-26-093853
Jun 22, 202615-12G0001140361-26-025858
Jun 16, 2026EFFECT9999999995-26-002005
Jun 11, 2026S-8 POS0001193125-26-267678
Jun 11, 2026S-8 POS0001193125-26-267702
Jun 11, 202640001594774-26-000002
Jun 11, 202640001298146-26-000002
Jun 11, 2026S-8 POS0001193125-26-267588
Jun 11, 2026S-8 POS0001193125-26-267581
Jun 11, 2026S-8 POS0001193125-26-267594
Jun 11, 2026S-8 POS0001193125-26-267548
Jun 11, 2026S-8 POS0001193125-26-267709
Jun 11, 202640001959750-26-000003
Jun 11, 2026S-8 POS0001193125-26-267575
Jun 11, 2026S-8 POS0001193125-26-267555
Jun 11, 2026S-8 POS0001193125-26-267643
Jun 11, 20268-K0001140361-26-024949
Jun 11, 2026SC 14D9/A0001140361-26-024885
Jun 11, 2026S-8 POS0001193125-26-267697
Jun 11, 2026S-8 POS0001193125-26-267530
Jun 11, 2026POS AM0001193125-26-267506
Jun 11, 2026S-8 POS0001193125-26-267628